Epic sciences unveils new liquid biopsy test to predict sensitivity to PARP inhibitors in prostate cancer trial

April 9, 2019 Leave a comment 858 Views

Epic Sciences, Inc. and its research partners today report the use of the company’s new circulating tumor cell (CTC) homologous recombination deficiency (HRD) liquid biopsy assay for the prediction of...

Exosome RNA Exosome RNA Research & Industry News

Tag Archives: Epic Science

Epic sciences unveils new liquid biopsy test to predict sensitivity to PARP inhibitors in prostate cancer trial

Upcoming Webinar – Ferrohydrodynamic isolation of circulating tumor cells and exosomes

Plasmonic olocrimetric biosensor for sensitive exosome detection

Development of a simple, sensitive and selective colorimetric aptasensor for the detection of cancer-derived exosomes

miR Scientific announces FDA breakthrough device designation for its prostate cancer liquid biopsy test

Could A Nasal Spray Of “Nanovesicles” Repair Brain Cells?

Isolation of exosomes from whole blood by a new microfluidic device